Health
Jonathan Wall receives $1.79 million to develop new amyloidosis treatment – EurekAlert
The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science…
IMAGE: Dr. Jonathan Wall
view more
Credit: UTHSC
Memphis, Tenn. (March 16, 2021) – The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled “Developing a Theranostic Immunotherapy for Systemic Amyloidosis.”
Amyloidosis is a rare disease that occurs when abnormal protein aggregates (called amyloid)…
-
Noosa News23 hours agoMan allegedly killed at teenage house party identified as co-founder of Universal Store
-
Noosa News23 hours agoRising talent shine at Noosa International Surfilm Festival 2025
-
Business24 hours agoSuncorp shares push higher on big leadership news
-
Business20 hours agoThe best ASX retail shares to buy in FY26